The enhanced anti-tumour function of PTPN22-deficient CD8+ T cells was particularly evident in response to tumours expressing low-affinity TCR antigens and was associated with elevated cytokine secretion and direct TCR-dependent cytotoxicity. This evidence concerns the gene CD8A and neoplasm.